Answer
A moderate amount of human data (300–1000 pregnancy outcomes) indicates no malformations or fetal/neonatal toxicity with rilpivirine hydrochloride; however, exposure is lower during pregnancy, so viral load should be monitored closely.
Sources for this answer
- Edurant 25 mg tablets (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 21Document updated
Sources checked